197 related articles for article (PubMed ID: 24948789)
1. Oncocytic adenomas of thyroid-mimicking benign or metastatic disease on 18F-FDG-PET scan.
Zandieh S; Pokieser W; Knoll P; Sonneck-Koenne C; Kudlacek M; Mirzaei S
Acta Radiol; 2015 Jun; 56(6):709-13. PubMed ID: 24948789
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic accuracy and prognostic value of 18F-FDG PET in Hürthle cell thyroid cancer patients.
Pryma DA; Schöder H; Gönen M; Robbins RJ; Larson SM; Yeung HW
J Nucl Med; 2006 Aug; 47(8):1260-6. PubMed ID: 16883003
[TBL] [Abstract][Full Text] [Related]
3. Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization.
Choi JY; Lee KS; Kim HJ; Shim YM; Kwon OJ; Park K; Baek CH; Chung JH; Lee KH; Kim BT
J Nucl Med; 2006 Apr; 47(4):609-15. PubMed ID: 16595494
[TBL] [Abstract][Full Text] [Related]
4. Focal uptake of fluorodeoxyglucose by the thyroid in patients undergoing initial disease staging with combined PET/CT for non-small cell lung cancer.
Yi JG; Marom EM; Munden RF; Truong MT; Macapinlac HA; Gladish GW; Sabloff BS; Podoloff DA
Radiology; 2005 Jul; 236(1):271-5. PubMed ID: 15987980
[TBL] [Abstract][Full Text] [Related]
5. The usefulness of standardized uptake value in differentiation between benign and malignant thyroid lesions detected incidentally in 18F-FDG PET/CT examination.
Stangierski A; Woliński K; Czepczyński R; Czarnywojtek A; Lodyga M; Wyszomirska A; Janicka-Jedyńska M; Bączyk M; Ruchała M
PLoS One; 2014; 9(10):e109612. PubMed ID: 25296297
[TBL] [Abstract][Full Text] [Related]
6. 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma.
Kim TY; Kim WB; Ryu JS; Gong G; Hong SJ; Shong YK
Laryngoscope; 2005 Jun; 115(6):1074-8. PubMed ID: 15933524
[TBL] [Abstract][Full Text] [Related]
7. 18F-fluorodeoxyglucose positron emission tomography does not predict malignancy in thyroid nodules cytologically diagnosed as follicular neoplasm.
Kim JM; Ryu JS; Kim TY; Kim WB; Kwon GY; Gong G; Moon DH; Kim SC; Hong SJ; Shong YK
J Clin Endocrinol Metab; 2007 May; 92(5):1630-4. PubMed ID: 17284624
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of thyroid incidentalomas identified by 18F-FDG PET/CT: correlation of ultrasonograpy findings with cytology results.
Demir Ö; Köse N; Özkan E; Ünlütürk U; Aras G; Erdoğan MF
Nucl Med Commun; 2016 Jul; 37(7):715-20. PubMed ID: 26963467
[TBL] [Abstract][Full Text] [Related]
9. 18F-FDG PET of patients with Hürthle cell carcinoma.
Lowe VJ; Mullan BP; Hay ID; McIver B; Kasperbauer JL
J Nucl Med; 2003 Sep; 44(9):1402-6. PubMed ID: 12960183
[TBL] [Abstract][Full Text] [Related]
10. Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility.
Basu S; Li G; Bural G; Alavi A
Acta Radiol; 2009 Mar; 50(2):201-4. PubMed ID: 19089692
[TBL] [Abstract][Full Text] [Related]
11. Comparison of 11C-methionine PET and 18F-fluorodeoxyglucose PET in differentiated thyroid cancer.
Phan HT; Jager PL; Plukker JT; Wolffenbuttel BH; Dierckx RA; Links TP
Nucl Med Commun; 2008 Aug; 29(8):711-6. PubMed ID: 18753824
[TBL] [Abstract][Full Text] [Related]
12. Incidental ¹⁸F-FDG uptake in the thyroid in patients diagnosed with PET/CT for other malignancies.
Czepczyński R; Stangierski A; Oleksa R; Janicka-Jedyńska M; Czarnywojtek A; Ruchała M; Sowiński J
Nucl Med Rev Cent East Eur; 2011; 14(2):68-72. PubMed ID: 22474717
[TBL] [Abstract][Full Text] [Related]
13. Pathology results in [18F]fluorodeoxyglucose positron emission tomography of the thyroid gland.
Wolf G; Aigner RM; Schaffler G; Schwarz T; Krippl P
Nucl Med Commun; 2003 Dec; 24(12):1225-30. PubMed ID: 14627848
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of thyroid FDG uptake incidentally identified on FDG-PET/CT imaging.
Chen W; Parsons M; Torigian DA; Zhuang H; Alavi A
Nucl Med Commun; 2009 Mar; 30(3):240-4. PubMed ID: 19262287
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of focal and diffuse thyroid diseases identified by (18)F-fluorodeoxyglucose positron emission tomography.
Salvatori M; Melis L; Castaldi P; Maussier ML; Rufini V; Perotti G; Rubello D
Biomed Pharmacother; 2007 Sep; 61(8):488-93. PubMed ID: 17604940
[TBL] [Abstract][Full Text] [Related]
16. Role of 18F-fluorodeoxyglucose positron emission tomography in preoperative assessment of cytologically indeterminate thyroid nodules.
Sebastianes FM; Cerci JJ; Zanoni PH; Soares J; Chibana LK; Tomimori EK; de Camargo RY; Izaki M; Giorgi MC; Eluf-Neto J; Meneghetti JC; Pereira MA
J Clin Endocrinol Metab; 2007 Nov; 92(11):4485-8. PubMed ID: 17684046
[TBL] [Abstract][Full Text] [Related]
17. [Interpretation of thyroid incidentalomas in (18)F-FDG PET/CT studies].
Achury C; Estorch M; Domènech A; Camacho V; Flotats A; Jaller R; Geraldo L; Deportós J; Montes A; Carrió I
Rev Esp Med Nucl Imagen Mol; 2014; 33(4):205-9. PubMed ID: 24560597
[TBL] [Abstract][Full Text] [Related]
18. The role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography whole body imaging in the evaluation of focal thyroid incidentaloma.
Zhai G; Zhang M; Xu H; Zhu C; Li B
J Endocrinol Invest; 2010 Mar; 33(3):151-5. PubMed ID: 19783895
[TBL] [Abstract][Full Text] [Related]
19. Review. 18F-FDG PET in the diagnosis and follow-up of thyroid malignancy.
Al-Nahhas A; Khan S; Gogbashian A; Banti E; Rampin L; Rubello D
In Vivo; 2008; 22(1):109-14. PubMed ID: 18396792
[TBL] [Abstract][Full Text] [Related]
20. Diffuse and diffuse-plus-focal uptake in the thyroid gland identified by using FDG-PET: prevalence of thyroid cancer and Hashimoto's thyroiditis.
Kurata S; Ishibashi M; Hiromatsu Y; Kaida H; Miyake I; Uchida M; Hayabuchi N
Ann Nucl Med; 2007 Aug; 21(6):325-30. PubMed ID: 17705011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
